BG60832B2 - Фармацевтичен състав с аналгетична активност - Google Patents

Фармацевтичен състав с аналгетична активност Download PDF

Info

Publication number
BG60832B2
BG60832B2 BG98593A BG9859394A BG60832B2 BG 60832 B2 BG60832 B2 BG 60832B2 BG 98593 A BG98593 A BG 98593A BG 9859394 A BG9859394 A BG 9859394A BG 60832 B2 BG60832 B2 BG 60832B2
Authority
BG
Bulgaria
Prior art keywords
ibuprofen
arginine
sodium bicarbonate
pharmaceutical composition
granulate
Prior art date
Application number
BG98593A
Other languages
Bulgarian (bg)
English (en)
Inventor
Annibale Gazzaniga
Valter Gianesello
Federico Stroppolo
Luigi Vigano
Original Assignee
Zambon Group S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S.P.A. filed Critical Zambon Group S.P.A.
Publication of BG60832B2 publication Critical patent/BG60832B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BG98593A 1986-08-01 1994-02-25 Фармацевтичен състав с аналгетична активност BG60832B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21358/86A IT1197038B (it) 1986-08-01 1986-08-01 Composizione farmaceutica ad attivita' analgesica

Publications (1)

Publication Number Publication Date
BG60832B2 true BG60832B2 (bg) 1996-04-30

Family

ID=11180633

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98593A BG60832B2 (bg) 1986-08-01 1994-02-25 Фармацевтичен състав с аналгетична активност

Country Status (17)

Country Link
US (1) US4834966A (xx)
JP (1) JP2585005B2 (xx)
AT (1) AT394945B (xx)
AU (1) AU595342B2 (xx)
BE (1) BE1002109A3 (xx)
BG (1) BG60832B2 (xx)
CA (1) CA1286992C (xx)
CH (1) CH673394A5 (xx)
DE (1) DE3725176C2 (xx)
FR (1) FR2602141B1 (xx)
GB (1) GB2193093B (xx)
GR (1) GR871197B (xx)
IE (1) IE60276B1 (xx)
IT (1) IT1197038B (xx)
MX (1) MX9203167A (xx)
NL (1) NL194031C (xx)
ZA (1) ZA875397B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
JPH0256416A (ja) * 1988-08-19 1990-02-26 Daikyo Yakuhin Kogyo Kk 苦味を抑えた顆粒剤
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1264857B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1266583B1 (it) * 1993-07-30 1997-01-09 Zambon Spa Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
DE19800812C2 (de) * 1998-01-12 2000-05-11 Juergen C Froelich Verbesserte orale Darreichungsformen von L-Arginin-HCl
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
DE60035365T2 (de) * 1999-09-29 2008-02-28 R.P. Scherer Technologies, Inc., Las Vegas Granulate von arzneistoffsalzen mit hydrolisierter cellulose
US20020064550A1 (en) * 2000-09-07 2002-05-30 Akpharma, Inc. Edible candy compositions and methods of using same
US20020099037A1 (en) * 2001-01-19 2002-07-25 Akpharma, Inc. Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
AU2002244865A1 (en) * 2001-03-02 2002-09-19 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
BRPI0409127A (pt) * 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
JP4913359B2 (ja) * 2004-05-07 2012-04-11 第一三共ヘルスケア株式会社 イブプロフェン含有医薬組成物
AU2005247048B2 (en) 2004-05-28 2007-12-13 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2546258T3 (es) * 2005-03-22 2015-09-22 Stada Arzneimittel Ag Ibuprofeno solubilizado
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
SG176221A1 (en) * 2009-06-22 2012-01-30 Wyeth Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
ES2353541B1 (es) 2009-07-30 2011-09-20 Farmalider, S.A. Combinacion de ingredientes activos cosmeticos y composicion cosmetica obtenida a partir de la misma, y su utilizacion.
CN101810568A (zh) * 2010-03-29 2010-08-25 南京泛太化工医药研究所 含有布洛芬的注射剂及其制备方法
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2036890B1 (xx) * 1969-04-15 1973-01-12 Orsymonde
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions

Also Published As

Publication number Publication date
DE3725176A1 (de) 1988-02-04
JP2585005B2 (ja) 1997-02-26
IE871745L (en) 1988-02-01
JPS6341420A (ja) 1988-02-22
AU7554087A (en) 1988-02-04
CH673394A5 (xx) 1990-03-15
NL194031C (nl) 2001-05-03
IT8621358A0 (it) 1986-08-01
IT8621358A1 (it) 1988-02-01
CA1286992C (en) 1991-07-30
AT394945B (de) 1992-07-27
GB8716301D0 (en) 1987-08-19
NL8701729A (nl) 1988-03-01
FR2602141B1 (fr) 1990-11-30
BE1002109A3 (fr) 1990-07-10
AU595342B2 (en) 1990-03-29
US4834966A (en) 1989-05-30
ZA875397B (en) 1988-02-01
GB2193093B (en) 1990-03-28
ATA187887A (de) 1992-01-15
DE3725176C2 (de) 1995-06-14
IT1197038B (it) 1988-11-25
GR871197B (en) 1987-12-04
MX9203167A (es) 1992-07-01
FR2602141A1 (fr) 1988-02-05
IE60276B1 (en) 1994-06-29
NL194031B (nl) 2001-01-02
GB2193093A (en) 1988-02-03

Similar Documents

Publication Publication Date Title
BG60832B2 (bg) Фармацевтичен състав с аналгетична активност
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
KR100360130B1 (ko) 플루옥세틴약제학적제제
EP0266113B1 (en) Spray dried acetaminophen
US7482377B2 (en) Pharmaceutical compositions and methods of treatment based on diclofenac
US4734276A (en) L-lysine pyruvate and l- histidine pyruvate and their use in therapy of tissue and mucosa damage
PL142890B1 (en) Method of obtaining biphase niphedipin containing solid agent
JPH0587492B2 (xx)
CA3019257A1 (en) A pharmaceutical formulation of palbociclib and a preparation method thereof
CA1298199C (en) Spray dried acetaminophen
JP3784843B2 (ja) 鎮痛作用を有する薬剤組成物
ES2248802T3 (es) Procedimiento para producir preparaciones de flavanolignanos.
JP2879905B2 (ja) イブプロフェン含有経口投与用組成物
KR101046789B1 (ko) 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
JP2613714B2 (ja) ヒト血小板凝集阻害剤
CN113214206B (zh) 橙皮素与甜菜碱共晶物b及制备方法和其组合物与用途
JP2002536401A (ja) メタミゾール含有起泡性医薬組成物
HU204997B (en) Process for producing carrier system suitable for ensuring controlled biological access to dihydropyridines, as well as new oral dosage form ensuring improved biological access
KR0142924B1 (ko) 편자 마이크로캅셀의 제조방법
KR20030072848A (ko) 진통효과를 갖는 조성물 및 그의 제조방법